Asthma-III: Symptoms and Complications

Asthma is classified into intermittent and persistent categories. Intermittent asthma involves milder symptoms occurring fewer than twice weekly with normal lung function between episodes. Persistent asthma subdivides into mild, moderate, and severe based on daily symptom frequency, nighttime awakenings, and lung function measurements (FEV1 or peak flow percentages). Severe persistent asthma involves daily symptoms with frequent nighttime awakenings and severely reduced lung function below 60% of predicted values.

Common asthma symptoms include chronic coughing, especially at night or early morning, wheezing (a high-pitched whistling sound during exhalation), shortness of breath particularly during exertion, and chest tightness. Excessive mucus production causes congestion and phlegm buildup, making airway clearance difficult. Sometimes a persistent cough may be the only symptom, especially in mild cases or during early stages of the condition.

Wheezing results from airway narrowing caused by asthma inflammation and mucus accumulation. As air passes through these constricted airways during exhalation, it produces a characteristic high-pitched whistling sound. The degree of wheezing correlates with airway constriction severity. Patients may experience wheezing during physical activity, exposure to cold air, or contact with pollutants, which further narrow airways and increase respiratory difficulty.

Poorly managed asthma can lead to reduced lung function, respiratory failure, atelectasis (collapsed lung tissue), and pneumonia. Status asthmaticus is a severe, life-threatening asthma attack unresponsive to standard treatments. Long-term inflammation causes airway remodeling with permanent structural changes. Frequent exacerbations requiring emergency treatment or hospitalization significantly impact quality of life through activity limitations, disturbed sleep, and psychological effects including anxiety and depression.

Excessive mucus production in asthma causes airway congestion and phlegm buildup, making it difficult for patients to clear their airways through coughing. This mucus accumulation narrows airways further, contributing to wheezing and shortness of breath. The combination of inflammation, mucus, and airway constriction creates a cycle that worsens respiratory symptoms and reduces oxygen flow, particularly during physical activity or exposure to environmental triggers.

Lung function, measured by FEV1 (forced expiratory volume in one second) or peak flow, is central to asthma classification. Intermittent asthma shows normal lung function between episodes. Mild persistent asthma maintains FEV1 above 80% of predicted values. Moderate persistent asthma shows 60-80% of predicted values, while severe persistent asthma drops below 60%. During flare-ups, lung function temporarily decreases, reflecting airway constriction and reduced airflow severity.

Asthma symptoms are triggered by allergens, cold air, exercise, and respiratory infections. Cold climates and pollutant exposure cause particular difficulty breathing in asthmatic individuals. These environmental factors prompt airway inflammation and mucus production, narrowing airways and triggering wheezing, coughing, and shortness of breath. Symptom severity depends on individual sensitivity and asthma classification, with poorly managed asthma showing more pronounced responses to environmental triggers.